Condition category
Skin and Connective Tissue Diseases
Date applied
21/05/2010
Date assigned
21/05/2010
Last edited
29/07/2013
Prospective/Retrospective
Retrospectively registered
Overall trial status
Completed
Recruitment status
No longer recruiting

Plain English Summary

Not provided at time of registration

Trial website

Contact information

Type

Scientific

Primary contact

Prof Chris Griffiths

ORCID ID

Contact details

Stott Lane
Salford
M6 8HD
United Kingdom
chris.griffiths@srft.nhs.uk

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

7310

Study information

Scientific title

Acronym

Web based cognitive behaviour therapy for people with psoriasis

Study hypothesis

Psoriasis is a chronic inflammatory skin disease affecting approximately 2-3% of the population. The condition is incurable at this stage and the course is recurrent, with periods of remission. It is believed to be a genetic disease, with the genetic tendency thought to be triggered by various environmental factors including infection, skin trauma, certain medications and stress.

Previous research has shown that psoriasis patients have a high incidence of psychological distress, with studies reporting psychological disturbance in the order of 30 - 40% of patients. Psychological distress reported by psoriasis patients includes increased levels of anxiety, depression, excessive worry, reduced quality of life and impaired everyday functioning. Overall, psoriasis patients report more psychological distress than any other dermatology group.

Ethics approval

MREC approved (ref: 08/H1012/17)

Study design

Single centre randomised interventional treatment trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

GP practices

Trial type

Treatment

Patient information sheet

Condition

Topic: Skin; Subtopic: Skin (all Subtopics); Disease: Dermatology

Intervention

Cognitive behaviour therapy (CBT) in a web-based format. This method allows participants to complete the study in privacy, at their own convenience and makes the treatment more broadly accessible.

Follow up length: 6 months

Intervention type

Other

Phase

Not Specified

Drug names

Primary outcome measures

Subjective reports of self efficacy

Secondary outcome measures

1. Change in illness beliefs
2. Improved quality of life
3. Reduced alcohol consumption

Overall trial start date

01/04/2009

Overall trial end date

31/12/2009

Reason abandoned

Eligibility

Participant inclusion criteria

Male and female, lower age limit of 16 years

Participant type

Patient

Age group

Adult

Gender

Both

Target number of participants

Planned sample size: 120

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/04/2009

Recruitment end date

31/12/2009

Locations

Countries of recruitment

United Kingdom

Trial participating centre

Stott Lane
Salford
M6 8HD
United Kingdom

Sponsor information

Organisation

Salford Royal NHS Foundation Trust (UK)

Sponsor details

Hope Hospital
Stott Lane
Salford
M6 8HD
United Kingdom

Sponsor type

Government

Website

http://www.srht.nhs.uk

Funders

Funder type

Charity

Funder name

Psoriasis and Psoriatic Arthritis Alliance (PAPAA) (UK)

Alternative name(s)

PAPAA

Funding Body Type

private sector organisation

Funding Body Subtype

other non-profit

Location

United Kingdom

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Participant level data

Not provided at time of registration

Results - basic reporting

Publication summary

2013 results in http://www.ncbi.nlm.nih.gov/pubmed/23551271

Publication citations

  1. Results

    Bundy C, Pinder B, Bucci S, Reeves D, Griffiths CE, Tarrier N, A novel, web-based, psychological intervention for people with psoriasis: the electronic Targeted Intervention for Psoriasis (eTIPs) study., Br. J. Dermatol., 2013, 169, 2, 329-336, doi: 10.1111/bjd.12350.

Additional files

Editorial Notes